<DOC>
	<DOC>NCT01565577</DOC>
	<brief_summary>This study aims to estimate the vaccinal immunity four years after four doses of MenbVac in children aged 4-8 years.</brief_summary>
	<brief_title>Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVacÂ® (Extension MenbVac)</brief_title>
	<detailed_description />
	<criteria>children born between 01/01/2000 and 06/23/2005, living in DieppeEst, DieppeOuest and Offranville, vaccinated with four doses of MenBVac in the first MenbVac clinical trial study, parental authority(ies)assent. no parental authority(ies)assent, no parental authority(ies)assent, no blood sample during the third vaccination, impossibility of third vaccination.</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Neisseria meningitidis B:14, P1-7, 16</keyword>
	<keyword>Serum bactericidal activity</keyword>
	<keyword>Menbvac</keyword>
</DOC>